Literature DB >> 19415770

Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.

Chia-Wei Chang1, Yi-Shin Lai, Kevin M Pawlik, Kaimao Liu, Chiao-Wang Sun, Chao Li, Trenton R Schoeb, Tim M Townes.   

Abstract

We report the derivation of induced pluripotent stem (iPS) cells from adult skin fibroblasts using a single, polycistronic lentiviral vector encoding the reprogramming factors Oct4, Sox2, and Klf4. Porcine teschovirus-1 2A sequences that trigger ribosome skipping were inserted between human cDNAs for these factors, and the polycistron was subcloned downstream of the elongation factor 1 alpha promoter in a self-inactivating (SIN) lentiviral vector containing a loxP site in the truncated 3' long terminal repeat (LTR). Adult skin fibroblasts from a humanized mouse model of sickle cell disease were transduced with this single lentiviral vector, and iPS cell colonies were picked within 30 days. These cells expressed endogenous Oct4, Sox2, Nanog, alkaline phosphatase, stage-specific embryonic antigen-1, and other markers of pluripotency. The iPS cells produced teratomas containing tissue derived from all three germ layers after injection into immunocompromised mice and formed high-level chimeras after injection into murine blastocysts. iPS cell lines with as few as three lentiviral insertions were obtained. Expression of Cre recombinase in these iPS cells resulted in deletion of the lentiviral vector, and sequencing of insertion sites demonstrated that remnant 291-bp SIN LTRs containing a single loxP site did not interrupt coding sequences, promoters, or known regulatory elements. These results suggest that a single, polycistronic "hit and run" vector can safely and effectively reprogram adult dermal fibroblasts into iPS cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415770     DOI: 10.1002/stem.39

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  91 in total

Review 1.  Vascular potential of human pluripotent stem cells.

Authors:  Ionela Iacobas; Archana Vats; Karen K Hirschi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-07       Impact factor: 8.311

2.  Methods of cell purification: a critical juncture for laboratory research and translational science.

Authors:  Peter J Amos; Esra Cagavi Bozkulak; Yibing Qyang
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

Review 3.  Pluripotent stem cells: origin, maintenance and induction.

Authors:  Maria P De Miguel; Sherezade Fuentes-Julián; Yago Alcaina
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 4.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 5.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

Review 6.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

Review 7.  An experimental approach to the generation of human embryonic stem cells equivalents.

Authors:  Katarzyna Skowron; Marcin Tomsia; Piotr Czekaj
Journal:  Mol Biotechnol       Date:  2014-01       Impact factor: 2.695

8.  Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen.

Authors:  Francisco Dieguez-Acuña; Shohta Kodama; Yoshiaki Okubo; Ana Cristina Paz; Steven P Gygi; Denise L Faustman
Journal:  Int J Biochem Cell Biol       Date:  2009-12-18       Impact factor: 5.085

Review 9.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

Review 10.  Gene-delivery systems for iPS cell generation.

Authors:  Lijian Shao; Wen-Shu Wu
Journal:  Expert Opin Biol Ther       Date:  2010-02       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.